Discovery of a Potent and Selective ATAD2 Bromodomain Inhibitor with Antiproliferative Activity in Breast Cancer Models. - Winter-Holt JJ; Bardelle C; Chiarparin E; Dale IL; Davey PRJ; Davies NL; Denz C; Fillery SM; Guérot CM; Han F; Hughes SJ; Kulkarni M; et al. (Journal of medicinal chemistry, 2022)